Aigner A, Ray P E, Czubayko F, Wellstein A.
Immunolocalization of an FGF-binding protein reveals a
widespread expression pattern during different stages of mouse embryo
development.
Histochem Cell Biol 117
(2002) 1-11
Aigner A, Renneberg H, Bojunga J, Apel J,
Nelson P, Czubayko F.
Ribozyme-targeting of a secreted FGF-binding protein
(FGF-BP) inhibits proliferation of prostate cancer cells in vitro and
in vivo.
Oncogene 21(37)
(2002) 5733-42
Aigner A, Fischer D, Merdan T, Brus C,
Kissel T, Czubayko F.
Delivery of unmodified bioactive ribozymes by an
RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates
gene expression.
Gene Ther 9(24)
(2002) 1700-1707
Krüger M, Regenthal R, Böhm R, Lindner
D, Trauer H, Caffier P:
Letale Diethylenglykol-Intoxikation nach missbräuchlicher
Anwendung von Goldgeist® forte.
Anästhesiologie und Intensivmedizin 43
(2002) 21-26.
Jäger R, List B, Knabbe C, Souttou
B, Raulais D, Zeiler T, Wellstein A, Aigner A, Neubauer A, Zugmaier G.
Serum levels of the angiogenic factor pleiotrophin in
relation to disease stage in lung cancer patients.
Jäger R1, List B, Knabbe C, Souttou B, Raulais D, Zeiler T,
Wellstein A, Aigner A, Neubauer A, Zugmaier G.
Br J Cancer 86
(2002) 858-863
Ludewig R, Preiss R, Regenthal R, Illes P, Kleemann WJ,
Krüger N, Schreinicke G:
Aktuelles zu Arzneimitteln und Giften. Ärzteblatt Sachsen 11
(2002) 530-535.
Preiss R, Schmidt R, Baumann F, Hanschmann
H, Hauss J,
Geissler F, Pahlig H, Ratzewiss B:
Measurement of 4-hydroxylation of ifosfamide in human liver microsomes
using the estimation of free and protein-bound acrolein and
codetermination of keto- and carboxyifosfamide.
J Cancer Res Clin Oncol 128 (2002) 385-392.
Preiss R:
Antidepressiva und obere gastrointestinale Blutung.
Arzneiverordnung in der Praxis 1 (2002) 16.
Regenthal R, Krüger M, Trauer H,
Boehm R,
Preiss R:
Evaluation of REMEDI HS in the diagnosis of dimethoate poisoning.
Therapeutic Drug Monitoring 24 (2002) 297-301.
Regenthal R, Preiss R:
Telithromycin (Ketek®). Arzneimittelverordnung in der Praxis 2
(2002) 10.
Regenthal R, Stefanovic D, Albert T, Trauer
H, Wolf T:
The pharmacologic stability of 35-years old theophylline.
Hum Exp Toxicol 21 (2002) 343-346.
Powers C, aigner A, Stoica G E, McDonnell K, Wellstein A.
Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.
J Biol Chem 277(16) (2002) 14153-14158
Teichert J, Preiss R:
High-performance liquid chromatographic assay for alpha-lipoic acid and
five of its metabolites in human plasma and urine.
J Chromatogr B 769 (2002) 269-281.
|